Results 21 to 30 of about 2,008 (186)

Treatment of dogs with fluralaner reduced pyrethroid-resistant Triatoma infestans abundance, Trypanosoma cruzi infection and human-triatomine contact in the Argentine Chaco [PDF]

open access: yesParasites & Vectors, 2022
Background Triatomine elimination efforts and the interruption of domestic transmission of Trypanosoma cruzi are hampered by pyrethroid resistance. Fluralaner, a long-lasting ectoparasiticide administered to dogs, substantially reduced site infestation ...
Ricardo Esteban Gürtler   +6 more
doaj   +2 more sources

The effect of food on the pharmacokinetics of oral fluralaner in dogs [PDF]

open access: yesParasites & Vectors, 2014
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. The pharmacokinetics of orally administered drugs may be influenced by feeding.
Feli M Walther   +3 more
doaj   +3 more sources

Evaluation of oral fluralaner (Bravecto®) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato) [PDF]

open access: goldParasites & Vectors, 2020
Background Amblyomma americanum and Rhipicephalus sanguineus (sensu lato) nymphs commonly feed on and transmit pathogens to dogs (Canis familiaris). Control of immature and adult tick life stages is necessary to fully protect animals.
Kelly Allen   +8 more
doaj   +2 more sources

Insecticidal activity of fluralaner (Exzolt®) administered to Gallus gallus domesticus against triatomines (Hemiptera, Reduviidae, Triatominae) [PDF]

open access: yesParasites & Vectors
Background Triatoma infestans, Triatoma brasiliensis, Triatoma pseudomaculata and Rhodnius prolixus are vectors of Trypanosoma cruzi, the etiological agent of Chagas disease. Chickens serve as an important blood food source for triatomines.
Luanderson Cardoso Pereira   +12 more
doaj   +2 more sources

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs [PDF]

open access: yesParasites & Vectors, 2015
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing immediate and persistent flea, tick and mite control after a single oral dose.
Feli M. Walther   +2 more
doaj   +3 more sources

Treatment of chickens with fluralaner induced mortality in pyrethroid-resistant Triatoma infestans (Hemiptera, Triatominae) [PDF]

open access: yesParasites & Vectors
Background Residual spraying with pyrethroid insecticides is still the main strategy used to prevent vector-borne transmission of Trypanosoma cruzi, the etiological agent of Chagas disease.
Mateo Rocha-Bazán   +8 more
doaj   +2 more sources

Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions [PDF]

open access: yesParasites & Vectors
Background Year-round control of canine flea and tick infestations requires owner compliance with recommendations for regular treatments. Compliance failures can result in increased exposure of dogs to tick-borne pathogens and resurgence of flea ...
Ivo Petersen   +8 more
doaj   +2 more sources

Pharmacokinetics of fluralaner as a systemic drug to control infestations of the common bed bug, Cimex lectularius, in poultry facilities [PDF]

open access: yesParasites & Vectors, 2023
Background Bed bug infestations are re-emerging in the poultry industry throughout the USA. Although the impacts of bed bugs on birds’ health and welfare are poorly understood, adverse outcomes are expected, including stress, anemia, infections and lower
Maria A. González-Morales   +9 more
doaj   +2 more sources

A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus) [PDF]

open access: goldParasites & Vectors, 2018
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) was developed for the treatment of nematode infections as well as providing 12 weeks of protection against insect and acarine parasites in cats.
Nadja Rohdich   +10 more
doaj   +2 more sources

Acaricidal efficacy of fluralaner against Rhipicephalus microplus ticks under laboratory and field conditions in Brazil. [PDF]

open access: goldParasit Vectors
Rodrigues DC   +13 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy